Description
Gale AI, Inc. is developing a mobile and desktop program, designed to use natural language processing (NLP), machine learning and artificial intelligence to review the procedure notes of medical providers, their assistants and nurses and translate them into relevant and accurate CPT codes, their appropriate modifiers, and associated diagnoses . . . all in a manner of seconds.
Terms of Use: https://galeai.co/EULA
Hide
Show More...
Terms of Use: https://galeai.co/EULA
In-Apps
- 1 Scan
- SAR 12.99
- 10 Scans
- SAR 99.99
- 25 Scans
- SAR 229.99
- 100 Scans
- SAR 999.99
- Mobile Subscription
- SAR 20.99
- Desktop Subscription
- SAR 172.99
Screenshots
GaleAI FAQ
-
Is GaleAI free?
Yes, GaleAI is free to download, however it contains in-app purchases or subscription offerings.
-
Is GaleAI legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does GaleAI cost?
GaleAI has several in-app purchases/subscriptions, the average in-app price is SAR 256.16.
-
What is GaleAI revenue?
To get estimated revenue of GaleAI app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Saudi Arabia yet.
Ratings History
GaleAI Reviews
No Reviews in Saudi Arabia
App doesn't have any reviews in Saudi Arabia yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
GaleAI Installs
Last 30 days
GaleAI Revenue
Last 30 daysGaleAI Revenue and Downloads
Gain valuable insights into GaleAI performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Productivity
- Publisher
- GaleAI
- Languages
- English
- Recent release
- 1.1.13 (1 year ago )
- Released on
- Jun 30, 2022 (2 years ago )
- Also available in
- United States, Poland, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Latvia, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Pakistan, Italy, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, Uzbekistan, Vietnam, South Africa, Denmark, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, United Arab Emirates, Dominican Republic, Algeria, Ecuador, Egypt, Finland, France, United Kingdom, Hong Kong SAR China, Croatia, Hungary, Indonesia, Ireland, Israel, India
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.